MedTrace Logo

The Effects of Upper Extremity Lymphedema on Posture, Upper Extremity Functions, and Quality of Life

NCT05776433 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 27

Last updated 2023-03-20

No results posted yet for this study

Summary

This study aims to examine the effects of lymphedema extremity on upper extremity function, posture and quality of life in patients who develop upper extremity lymphedema after unilateral breast cancer. Twenty-seven volunteers (27Female) diagnosed with upper extremity lymphedema after unilateral breast cancer treatment by a specialist physician between May 2022 and October 2022 were included in the study. Upper extremity circumference measurements of the individuals were performed on the healthy and affected sides. A goniometer measured both sides' upper extremity range of motion (ROM). The New York Posture Analysis (NYPA) was used for posture evaluation. Upper extremity functions were assessed by the Disabilities of the Arm, Shoulder and Hand (DASH) Questionnaire and the Lymphedema Functionality, Disability and Health Questionnaire (Lymph-ICF). Quality of life was assessed by Upper Extremity Lymphedema-27 (ULL-27) and Quality of Life Measure for Limb Lymphedema -Arm (LYMQOL- Arm).

Conditions

  • Breast Cancer Related Lymphedema
  • Breast Cancer-Related Arm Lymphedema

Sponsors & Collaborators

  • Yeditepe University

    lead OTHER

Principal Investigators

  • Simla Turan · Yeditepe University

  • Feryal Subaşı · Yeditepe University

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-02
Primary Completion
2022-05-02
Completion
2022-10-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05776433 on ClinicalTrials.gov